Recludix Pharma to Present at the Oppenheimer Private Life Sciences Company Showcase

ConferenceNeutral

AI Analysis

Summary

Recludix Pharma announced that its CEO and head of R&D will present at the Oppenheimer Private Life Sciences Company Showcase on September 29, 2026. The company is developing inhibitors targeting challenging disease mechanisms in inflammatory conditions.

Importance:2/10

Sentiment:

0.00

conference presentationinvestor relationsclinical-stageinflammatory disease

Read the original article

Published by GlobeNewswire Pharma on September 22, 2026 12:00 PM

Read Original